Thirty-two patients with coronary artery disease who underwent liver transplantation between 1990 and 1994 were identified. Coronary artery disease was managed medically (n = 9), by angioplasty (n = 1), or surgically (n = 22) prior to liver transplantation. Two patients underwent simultaneous corona
Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation
β Scribed by Norma C. McAvoy; Narendra Kochar; Graham McKillop; David E. Newby; Peter C. Hayes
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 186 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21540
No coin nor oath required. For personal study only.
β¦ Synopsis
Patients with advanced liver disease are at increased risk of cardiovascular events, especially following orthotopic liver transplantation (OLT). Coronary artery calcification (CAC) is a novel and independent predictor of cardiovascular risk, but its prevalence and utility in patients with cirrhosis are unknown. The aim of this study was to define the prevalence of CAC and its association with markers of disease severity and standard measures of cardiovascular risk in a large cohort of patients undergoing OLT assessment. A single-center, prospective, observational study of 147 consecutive patients undergoing assessment for OLT was performed. CAC scores were derived with the Agatston method from thoracic computed tomography scans and correlated with cardiovascular risk factors and measures of liver disease severity. There were 101 patients (66 males) with a mean age of 53.2 years; 46 patients were excluded because the CAC score was not reported. The median CAC score was 40 HU (range, 0-3533). Correlations were identified between the CAC score and age (r Ο 0.477; P Ο½ 0.001), male sex (r Ο 0.262; P Ο 0.008), family history of cardiovascular disease (r Ο 0.208; P Ο 0.036), Framingham risk score (r Ο 0.621; P Ο½ 0.001), Model for End-Stage Liver Disease score (r Ο 0.221; P Ο 0.027), systolic blood pressure (r Ο 0.285; P Ο 0.004), diastolic blood pressure (r Ο 0.267; P Ο 0.007), cytomegalovirus status (r Ο 0.278; P Ο 0.005), fasting glucose (r Ο 0.330; P Ο 0.001), number of coronary vessels involved (r Ο 0.899; P Ο½ 0.001), and components of the metabolic syndrome (r Ο 0.226; P Ο 0.026). After multivariate analysis, age, systolic blood pressure, fasting glucose, number of features of metabolic syndrome, and number of vessels involved remained significantly associated with CAC. In conclusion, this study identified a high prevalence of occult coronary artery disease in patients undergoing OLT assessment and identified a strong relationship between CAC scores and a limited number of specific cardiovascular risk factors. The usefulness of these factors in predicting perioperative and postoperative cardiovascular events in patients undergoing OLT requires prospective evaluation.
π SIMILAR VOLUMES
The prevalence of coronary artery disease in end-stage liver disease is only now being recognized. Liver transplant patients are a high risk subgroup for coronary artery disease, even if asymptomatic. Coronary artery disease is a predictor of poor outcomes; therefore, identification of those at risk
This study attempts to evaluate the efficacy of dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Two hundred twenty consecutively submitted patients were evaluated in preparation for orthotopic liver transplantat
Arterial conduits that use donor iliac arteries represent a reliable technique for graft revascularization in orthotopic liver transplantation. We reviewed 757 consecutive liver transplantations performed between 1989 and 1995 for acute or chronic liver disease in adults and children. Of these, 218
The greatest part of liver allograft injury occurs during reperfusion, not during the cold ischemia phase. The aim of this study, therefore, was to investigate how the severity of postreperfusion syndrome (PRS) influences short-term outcome for the patient and for the liver allograft. Over a 2-year